Evommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases
LOS ALTOS, Calif., Nov. 18, 2020 /PRNewswire/ -- Evommune, Inc., an innovation engine in chronic inflammation, announced the successful completion of a $12.5 million...